December 2017

You enter the University of Colorado Boulder’s newest research laboratory through the side entrance. The door—which is heavy and white, with a black, jug-style handle—slides open from right to left. Crammed inside are a plain wooden dresser, two chairs, and a small desk, above which someone has taped a mediocre landscape-print (mountains, trees, clouds, etc.). […]

by

More in Series: Cannabis on the Central Coast – Looking at land use, money, science, law enforcement and education (4 of 24) Students: Cannabis blown out of proportion by adults Read more … read more at: http://lompocrecord.com/news/local/education/health-officials-crafting-compelling-cannabis-message-for-youth/article_69a1fc11-7b7d-5e16-bfa5-96afe4bbdf9b.html

by

You enter the University of Colorado Boulder’s newest research laboratory through the side entrance. The door—which is heavy and white, with a black, jug-style handle—slides open from right to left. Crammed inside are a plain wooden dresser, two chairs, and a small desk, above which someone has taped a mediocre landscape-print (mountains, trees, clouds, etc.). […]

by

Following this week’s announcement by GW Pharmaceuticals plc (NASDAQ:GWPH) that the drug Epidiolex was accepted for filing with Priority Review by the U.S. Food and Drug Administration, comes news that the company submitted a Marketing Authorisation Application to the European Medicines Agency. In a statement released Friday GW noted that they have already received the […]

by

The Top Medical Cannabis Studies of 2017 In part one of this series, we took a look at some of the most impactful studies in medical cannabis, specifically those relating to CBD. This next installment highlights several cannabis wins beyond CBD, as it shows promise in healthy aging, neurodegenerative disease, and more. Cannabis is a […]

by

Successful stage III clinical trial for cannabidiol (CBD) treatment of epilepsy in children (New England Journal of Medicine, May 2017) Randomized, double-blind, placebo-controlled studies are the gold standard in clinical research, but this study design has been lacking in medicinal cannabis research until now. Scientists tested the effects of oral CBD (Epidolex from GW Pharmaceuticals) […]

by

Following this week’s announcement by GW Pharmaceuticals plc (NASDAQ:GWPH) that the drug Epidiolex was accepted for filing with Priority Review by the U.S. Food and Drug Administration, comes news that the company submitted a Marketing Authorisation Application to the European Medicines Agency. In a statement released Friday GW noted that they have already received the […]

by

The Top Medical Cannabis Studies of 2017 In part one of this series, we took a look at some of the most impactful studies in medical cannabis, specifically those relating to CBD. This next installment highlights several cannabis wins beyond CBD, as it shows promise in healthy aging, neurodegenerative disease, and more. Cannabis is a […]

by

The number of women who use marijuana while pregnant is increasing, especially among teenage and young pregnant mothers, a new report in the Journal of the American Medical Association (JAMA) suggested. “Marijuana is the most commonly used illicit drug during pregnancy,” the research letter published in JAMA on Tuesday stated. “And its use is increasing.” […]

by

VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has completed a prestudy visit of the Fundación de Investigación (“FDI”) facilities in San Juan, Puerto Rico.  This will be the site where the Company’s research arm, Cannevert Therapeutics Ltd. (“CTL”) will be […]

by